Friday, March 11, 2011

Educational Symposium on Macular Degeneration...

The Macular Degeneration Association would like to cordially invite you to our annual conference on macular degeneration. This year’s conference will be held on March 26, 2011 at the Tampa Westshore Marriott.This event is an excellent opportunity for you and your family to learn about the latest advances in macular degeneration research, drugs, treatments, and therapies. It will also serve as an opportunity for participants to share questions, concerns and ideas with nationally known macular experts, other local doctors, patients and caregivers.

There will be general session presentations beginning in the morning that will continue throughout the day, exhibition sessions during the sponsored breaks, and a question and answer session at the conclusion of the conference. Topics covered will include everything from genetic testing to future treatments of macular degeneration, as well as clinical trials currently being offered and other alternative therapies. 

The conference will run from 8:30am-5:00pm with registration open at 7:30am. Speakers include some of the most prominent names in the macular community, including Program Chair, Dr. Michael Tolentino, Dr. Dana Deupree, Dr. Sonya Braudway, Dr. Karen Gehrs, Dr. Benjamin Kim, Dr. Brian Madow, etc.

The Macular Degeneration Association is a nonprofit health organization providing macular research, information and advocacy. The mission of the organization is to help find a cure for macular degeneration and to improve the lives of all people affected by the disease.

To register or for more information about the March 26th Educational Conference, please contact Ms. Rosa Seminario at: rseminario@maculardegenerationassociation.org or call (800) 869-1551 ext. 0. To learn more about the Macular Degeneration Association please visit us online at http://www.maculardegenerationassociation.org/ We look forward to seeing you at our educational symposium. Thank you for your continued support.

No comments:

Post a Comment